Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

KEFLET

CEPHALEXIN

Standard Dose
EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview KEFLET is listed in Drugs@FDA under application 050440 (NDA).
  • Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 1991-07-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview KEFLET is listed in Drugs@FDA under application 050440 (NDA). Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 1991-07-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.